User menu

Modified method to measure nasal potential difference.

Bibliographic reference Leal, Teresinha ; Lebacq, Jean ; Lebecque, Patrick ; Cumps, Jean ; Wallemacq, Pierre. Modified method to measure nasal potential difference.. In: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 41, no. 1, p. 61-7 (2003)
Permanent URL http://hdl.handle.net/2078.1/9398
  1. Riordan, Rommens J., Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J., et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, 10.1126/science.2475911
  2. Schwiebert Erik M., Egan Marie E., Hwang Tae-Ho, Fulmer Stephanie B., Allen Sandra S., Cutting Garry R., Guggino William B., CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP, 10.1016/s0092-8674(05)80011-x
  3. Knowles Michael, Gatzy John, Boucher Richard, Increased Bioelectric Potential Difference across Respiratory Epithelia in Cystic Fibrosis, 10.1056/nejm198112173052502
  4. Alton EWFW, Eur Respir J, 3, 922 (1990)
  5. Alton E W, Hay J G, Munro C, Geddes D M, Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis., 10.1136/thx.42.10.815
  6. Hay J G, Geddes D M, Transepithelial potential difference in cystic fibrosis., 10.1136/thx.40.7.493
  7. Middleton P.G., Caplen N.J., Gao X., Huang L., Gaya H., Geddes D.M., Alton E.W.F.W., Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth, 10.1183/09031936.94.07030442
  8. Knowles M. R., Paradiso A. M., Boucher R. C., In VivoNasal Potential Difference: Techniques and Protocols for Assessing Efficacy of Gene Transfer in Cystic Fibrosis, 10.1089/hum.1995.6.4-445
  9. Rosenstein Beryl J., Cutting Garry R., The diagnosis of cystic fibrosis: A consensus statement, 10.1016/s0022-3476(98)70344-0
  10. Ho L.P., Samways J.M., Porteous D.J., Dorin J.R., Carothers A., Greening A.P., Innes J.A., Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis, 10.1183/09031936.97.10092018
  11. Fajac I., Hubert D., Bienvenu T., Richaud-Thiriez B., Matran R., Kaplan J-C., Dall'Ava-Santucci J., Dusser D.J., Relationships between nasal potential difference and respiratory function in adults with cystic fibrosis, 10.1183/09031936.98.12061295
  12. Duperrex O., Berclaz P-Y., Bertrand D., Lacroix J.S., Pochon N., Belli D., Rochat T., A new device for in vivo measurement of nasal transepithelial potential difference in cystic fibrosis patients and normal subjects, 10.1183/09031936.97.10071631
  13. Knowles M., Stutts M., Spock A, Fischer N, Gatzy J., Boucher R., Abnormal ion permeation through cystic fibrosis respiratory epithelium, 10.1126/science.6308769
  14. Hofmann T, Am J Respir Crit Care Med, 155, 1908 (1997)
  15. Southern Kevin W., Noone Peadar G., Bosworth Darin G., LeGrys Vicky A., Knowles Michael R., Barker Pierre M., A modified technique for measurement of nasal transepithelial potential difference in infants, 10.1067/mpd.2001.116278
  16. Ahrens Richard C., Standaert Thomas A., Launspach Janice, Han Seung-Ho, Teresi Mary E., Aitken Moira L., Kelley Thomas J., Hilliard Kathleen A., Milgram Laura J.H., Konstan Michael W., Weatherly Mark R., McCarty Nael A., Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis, 10.1002/ppul.10043
  17. Gibson LE, Pediatrics, 23, 545 (1959)
  18. Bland JM, Lancet, 1, 307 (1986)
  19. Conolly ME, Br J Pharmac, 46, 458 (1992)
  20. Delmarco A., Pradal U., Cabrini G., Bonizzato A., Mastella G., Nasal potential difference in cystic fibrosis patients presenting borderline sweat test, 10.1183/09031936.97.10051145
  21. Wilschanski M., Famini H., Strauss-Liviatan N., Rivlin J., Blau H., Bibi H., Bentur L., Yahav Y., Springer H., Kramer M.R., Klar A., Ilani A., Kerem B., Kerem E., Nasal potential difference measurements in patients with atypical cystic fibrosis, 10.1183/09031936.01.00092501
  22. Claustres Mireille, Guittard Caroline, Bozon Dominique, Chevalier Fran�oise, Verlingue Claudine, Ferec Claude, Girodon Emanuelle, Cazeneuve C�cile, Bienvenu Thierry, Lalau Guy, Dumur Viviane, Feldmann Delphine, Bieth Eric, Blayau Martine, Clavel Christine, Creveaux Isabelle, Malinge Marie-Claire, Monnier Nicole, Malzac Perrine, Mittre Herv�, Chomel Jean-Claude, Bonnefont Jean-Paul, Iron Albert, Chery Mich�le, Georges Marie Des, Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France, 10.1002/1098-1004(200008)16:2<143::aid-humu7>3.0.co;2-j
  23. Feldmann D, Clin Chem, 41, 1675 (1995)
  24. Vankeerberghen Anne, Wei Lin, Teng Hui, Jaspers Martine, Cassiman Jean-Jacques, Nilius Bernd, Cuppens Harry, Characterization of mutations located in exon 18 of theCFTRgene, 10.1016/s0014-5793(98)01042-4
  25. Friedman KJ, Pediatr Pulmonol, 19, 207 (1999)
  26. FitzSimmons SC, J Pediatr, 122, 1 (1993)
  27. Wilson David C., Ellis Lynda, Zielenski Julian, Corey Mary, Ip Wan F., Tsui Lap-Chee, Tullis Elizabeth, Knowles Michael R., Durie Peter R., Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements, 10.1016/s0022-3476(98)70345-2
  28. Lebecque P, Am J Respir Crit Care Med, 165, 757 (2002)